...
首页> 外文期刊>Cardiology >The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells.
【24h】

The effects of antihypertensive agents on atherosclerosis-related parameters of human aorta intimal cells.

机译:降压药对人主动脉内膜细胞动脉粥样硬化相关参数的影响。

获取原文
获取原文并翻译 | 示例

摘要

Four antihypertensive agents - amlodipine, verapamil, propranolol and perindoprilat - were studied in human cell cultures. Antiatherogenic activity was investigated using uninvolved human aortic smooth muscle intima cells and atherogenic serum obtained from patients with coronary atherosclerosis. Amlodipine and verapamil significantly inhibited serum-induced increases in cholesterol content, cell-proliferative activity and protein synthesis in the cultured cells. Propranolol increased all three parameters, while perindoprilat had no effects. In addition, amlodipine and verapamil significantly lowered the intracellular cholesterol content of smooth muscle cells derived from atherosclerotic plaque and inhibited cell proliferation and protein synthesis. Propranolol increased all of these parameters, while perindoprilat produced no effects. The antiatherogenic and antiatherosclerotic actions of verapamil and amlodipine were confirmed in an ex vivo model. These studies demonstrated a beneficial antiatherosclerotic effect of amlodipine that was greater than that of verapamil. Perindoprilat had a neutral effect on atherosclerotic parameters, while the action of propranolol appeared to be potentially detrimental.
机译:在人体细胞培养物中研究了四种降压药-氨氯地平,维拉帕米,普萘洛尔和培哚普利拉-。使用未参与的人主动脉平滑肌内膜细胞和从冠状动脉粥样硬化患者获得的动脉粥样硬化血清研究了抗动脉粥样硬化活性。氨氯地平和维拉帕米显着抑制血清诱导的培养细胞中胆固醇含量,细胞增殖活性和蛋白质合成的增加。普萘洛尔增加了所有三个参数,而培哚普利拉则没有影响。此外,氨氯地平和维拉帕米可显着降低源自动脉粥样硬化斑块的平滑肌细胞的细胞内胆固醇含量,并抑制细胞增殖和蛋白质合成。普萘洛尔增加了所有这些参数,而培哚普利拉则没有作用。在体外模型中证实了维拉帕米和氨氯地平的抗动脉粥样硬化作用和抗动脉粥样硬化作用。这些研究表明氨氯地平的有益抗动脉粥样硬化作用大于维拉帕米。 Perindoprilat对动脉粥样硬化参数具有中性作用,而普萘洛尔的作用似乎可能有害。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号